Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized prostate cancer screening: improving PSA tests with genomic information.

Science translational medicine - 15 Dec 2010

Witte John S

Abstract excerpt

The use of a prostate-specific antigen (PSA) test to screen for prostate cancer is controversial because of its modest predictive value and the potential overdiagnosis and over-treatment of the disease. A research article in this issue of Science Translational Medicine describes single-nucleotide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Early Detection of Cancer
Share to Kallikreins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Receptor, Fibroblast Growth Factor, Type 2

Share to T-Box Domain Proteins

Share to Telomerase

Source

Identifiers

PMID: 21160075
DOI: 10.1126/scitranslmed.3001861

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21160075-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized prostate cancer screening: improving PSA tests with genomic information.PMID 21160075Read ↗

A genetic-based approach to personalized prostate cancer screening and treatment.Semantic proximity Read ↗

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.Semantic proximity Read ↗

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.Semantic proximity Read ↗

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Semantic proximity Read ↗

Genetics and Screening in Prostate Cancer.Semantic proximity Read ↗

A comparison of genetic risk score with family history for estimating prostate cancer risk.Semantic proximity Read ↗

When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.Semantic proximity Read ↗

A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.Semantic proximity Read ↗

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.Semantic proximity Read ↗

Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease ManagementSemantic proximity Read ↗

Genetically Adjusted PSA Levels for Prostate Cancer ScreeningSemantic proximity Read ↗

Clinical validity and utility of genetic risk scores in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.